Cytomegalovirus in renal transplantation.
Cytomegalovirus (CMV) was first isolated from the salivary gland and kidney of two dying infants with cytomegalic inclusion bodies and reported in 1956 (1). Two other laboratories isolated CMV at approximately the same time. Thus, CMV was initially called "salivary gland virus" or "salivary gland inclusion disease virus". In 1960, Weller et al. (2) proposed the use of the term cytomegalovirus. Klemola and Kaarianinen (3) first described CMV mononucleosis, the principal presentation of previously healthy individuals, in 1965. CMV was first isolated in a renal transplant patient in 1965,
Brennan
Daniel C
DC
Department of Transplant Nephrology, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri.
D003587:Cytomegalovirus / Q000187:drug effects / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D004352:Drug Resistance, Microbial; D006801:Humans; D016030:Kidney Transplantation; D011183:Postoperative Complications